Russell Investments Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-3,411
| Closed | -$1.71K | – | 3926 |
|
2024
Q4 | $1.71K | Sell |
3,411
-150
| -4% | -$75 | ﹤0.01% | 3468 |
|
2024
Q3 | $13.3K | Sell |
3,561
-6,237
| -64% | -$23.3K | ﹤0.01% | 3036 |
|
2024
Q2 | $54.9K | Buy |
9,798
+7,486
| +324% | +$41.9K | ﹤0.01% | 2743 |
|
2024
Q1 | $12.1K | Sell |
2,312
-11,828
| -84% | -$62K | ﹤0.01% | 2827 |
|
2023
Q4 | $73.9K | Sell |
14,140
-1,325
| -9% | -$6.93K | ﹤0.01% | 2599 |
|
2023
Q3 | $244K | Buy |
15,465
+14,851
| +2,419% | +$234K | ﹤0.01% | 2448 |
|
2023
Q2 | $11.9K | Sell |
614
-2,879
| -82% | -$56K | ﹤0.01% | 2930 |
|
2023
Q1 | $99.1K | Sell |
3,493
-6,800
| -66% | -$193K | ﹤0.01% | 2592 |
|
2022
Q4 | $301K | Buy |
10,293
+6,800
| +195% | +$199K | ﹤0.01% | 2460 |
|
2022
Q3 | $92K | Sell |
3,493
-2,933
| -46% | -$77.3K | ﹤0.01% | 2679 |
|
2022
Q2 | $283K | Sell |
6,426
-4,587
| -42% | -$202K | ﹤0.01% | 2460 |
|
2022
Q1 | $543K | Sell |
11,013
-2,083
| -16% | -$103K | ﹤0.01% | 2199 |
|
2021
Q4 | $664K | Sell |
13,096
-5,972
| -31% | -$303K | ﹤0.01% | 2339 |
|
2021
Q3 | $1.06M | Sell |
19,068
-23,845
| -56% | -$1.33M | ﹤0.01% | 2158 |
|
2021
Q2 | $1.82M | Sell |
42,913
-54,620
| -56% | -$2.32M | ﹤0.01% | 1969 |
|
2021
Q1 | $4.06M | Buy |
97,533
+12,321
| +14% | +$513K | 0.01% | 1463 |
|
2020
Q4 | $3.96M | Sell |
85,212
-6,676
| -7% | -$311K | 0.01% | 1374 |
|
2020
Q3 | $3.89M | Buy |
91,888
+2,353
| +3% | +$99.7K | 0.01% | 1278 |
|
2020
Q2 | $4.29M | Buy |
89,535
+24,040
| +37% | +$1.15M | 0.01% | 1186 |
|
2020
Q1 | $3.01M | Buy |
65,495
+8,803
| +16% | +$405K | 0.01% | 1244 |
|
2019
Q4 | $3.41M | Sell |
56,692
-13,972
| -20% | -$839K | 0.01% | 1433 |
|
2019
Q3 | $4M | Buy |
70,664
+30,819
| +77% | +$1.74M | 0.01% | 1313 |
|
2019
Q2 | $2.22M | Buy |
39,845
+17,190
| +76% | +$957K | ﹤0.01% | 1623 |
|
2019
Q1 | $1.14M | Buy |
22,655
+8,348
| +58% | +$422K | ﹤0.01% | 1995 |
|
2018
Q4 | $576K | Buy |
14,307
+12,483
| +684% | +$503K | ﹤0.01% | 2263 |
|
2018
Q3 | $126K | Sell |
1,824
-4,008
| -69% | -$277K | ﹤0.01% | 2725 |
|
2018
Q2 | $441K | Buy |
5,832
+53
| +0.9% | +$4.01K | ﹤0.01% | 2435 |
|
2018
Q1 | $304K | Buy |
5,779
+4,908
| +563% | +$258K | ﹤0.01% | 2595 |
|
2017
Q4 | $48K | Sell |
871
-41
| -4% | -$2.26K | ﹤0.01% | 2872 |
|
2017
Q3 | $54K | Sell |
912
-45,172
| -98% | -$2.67M | ﹤0.01% | 2851 |
|
2017
Q2 | $3.63M | Buy |
46,084
+45,466
| +7,357% | +$3.59M | 0.01% | 1402 |
|
2017
Q1 | $51K | Sell |
618
-23,935
| -97% | -$1.98M | ﹤0.01% | 2901 |
|
2016
Q4 | $1.94M | Buy |
+24,553
| New | +$1.94M | ﹤0.01% | 1822 |
|